In this article, we recap the best ASX IPOs in the last decade.
Investing in IPOs is a big risk because there is no guarantee things will go well. It is…
Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn't reached without setbacks along…